ReviewCurrent urology reports2015
Management of neurogenic lower urinary tract dysfunction in multiple sclerosis patients.
Review in Current urology reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Effects of behavioural therapy versus interferential current on bladder dysfunction in multiple sclerosis patients; a randomised clinical study.Journal of Taibah University Medical Sciences · 2021Article
- Lower urinary tract dysfunction in common neurological diseases.Turkish journal of urology · 2020Review
- Nocturia in Patients With Multiple Sclerosis.Reviews in urology · 2019Article
- The Management of Lower Urinary Tract Dysfunction in Multiple Sclerosis.Current neurology and neuroscience reports · 2018Review
- Secondary and tertiary treatments for multiple sclerosis patients with urinary symptoms.Investigative and clinical urology · 2016Review
- Intradetrusorial Botulinum Toxin in Patients with Multiple Sclerosis: A Neurophysiological Study.Toxins · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multiple sclerosis (MS) can be a debilitating neurological condition that attributes significant morbidity to bladder dysfunction. Although many effective treatment options exist, symptomatic patients are often underdiagnosed and undertreated. The purpose of this article is to give an overview of the current literature including new screening tools to identify symptomatic patients and updates on treatment options including medications, botulinum toxin, and neuromodulation.
Indexed as
Identifiers
26025495What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.